February 8, 2021
Izzo NJ et al. Alzheimer’s Dement 2021;1–18.
Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification
Download publication
CellTalk
June 23, 2022
Proteomics/Mass Spectrometry
More infoPress Releases
May 19, 2022
Proteomics/Mass Spectrometry
More infoBrochures
November 8, 2021
Immune Monitoring
More info